Dr Reddy's Laboratories Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,280.00 +0.35 (0.03%)Updated : 15 Dec 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 25,800.5021,548.0019,449.8018,942.70
Other Net 190.80234.20628.9065.70
Diluted Weighted Average Shares 83.4283.3583.1983.17
Gain( Loss)on Saleof Assets 151.2090.00-121.10111.90
Depreciation/ Amortization 1,703.701,470.001,250.201,165.20
Operating Income 6,843.406,463.105,219.902,602.50
Net Income 5,655.105,577.904,507.302,182.50
Income Availableto Com Excl Extra Ord 5,655.105,577.904,507.302,178.10
Net Income Before Taxes 7,679.507,201.006,048.503,061.40
Minority Interest -70.100.000.000.00
Net Income After Taxes 5,725.205,577.904,507.302,178.10
Income Availableto Com Incl Extra Ord 5,655.105,577.904,507.302,182.50
Costof Revenue Total 10,783.408,939.808,304.807,997.20
Gross Profit 21,860.5019,071.3016,364.9013,548.00
Interest Inc( Exp) Net- Non- Op Total 494.10413.70320.80281.30
Unusual Expense( Income) 169.300.3069.90930.40
Diluted Net Income 5,655.105,577.904,507.302,182.50
DPS- Common Stock Primary Issue 8.008.008.006.00
Provisionfor Income Taxes 1,954.301,623.101,541.20883.30
period Type ----
Net Income Before Extra Items 5,655.105,577.904,507.302,178.10
Total Revenue 32,643.9028,011.1024,669.7021,545.20
period Length 12.0012.0012.0012.00
Revenue 32,643.9028,011.1024,669.7021,545.20
Selling/ General/ Admin Expenses Total 10,756.009,202.608,204.807,339.90
Diluted Normalized EPS 67.9566.0855.8933.19
Research Development 2,388.101,935.301,620.101,510.00
Diluted EPS Excluding Extra Ord Items 67.7966.9254.1826.19
Total Extraordinary Items ---4.40
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,292.70+31.65(1.40%)
1,687.00+14.60(0.87%)
172.95+1.05(0.61%)
3,604.00-74.90 (-2.04%)
2,065.20-18.15 (-0.87%)